Oaktree Acquisition Corp. III Life Sciences
OACCU· Nasdaq
OACCUOaktree Acquisition Corp. III Life Sciences
Filed May 13, 2026 · 10-Q · 43 days after period end · 0001193125-26-221814
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Net Income | $1.39M | $1.66M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oaktree Acquisition Corp. III Life Sciences · CIK 2029769 · Engraved from SEC EDGAR
ended Mar 31, 2026 · filed May 13, 2026 · 43 d after period end
